Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Revance The (RVNC) stocks
Learn how to easily invest in Revance The stocks.
Revance The is a biotechnology business based in the US. Revance The stocks (RVNC.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $32.77 – an increase of 1.97% over the previous week. Revance The employs 534 staff and has a trailing 12-month revenue of around $156.6 million.
How to buy Revance The stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – RVNC. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
CIBC Investor's Edge
- Easy to use platform
- Low fees
- Student and young investor discounts
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
What's in this guide?
- Can I buy shares in Revance The?
- Has coronavirus impacted Revance The shares?
- Revance The shares summary
- Compare share dealing platforms
- Is Revance The stock a buy or sell?
- Revance The performance over time
- Revance The's financials
- How volatile are Revance The shares?
- Does Revance The pay a dividend?
- Other common questions
Revance The stock price (NASDAQ:RVNC)Use our graph to track the performance of RVNC stocks over time.
Revance The shares at a glance
|Latest market close||$31.06|
|52-week range||$11.27 - $37.98|
|50-day moving average||$32.32|
|200-day moving average||$27.62|
|Wall St. target price||$39.42|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-4.82|
Buy Revance The stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Revance The stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Revance The price performance over time
Historical closes compared with the close of $31.06 from 2023-06-02
|1 week (2023-05-26)||1.97%|
|1 month (2023-05-04)||-8.05%|
|3 months (2023-03-03)||-6.19%|
|6 months (2022-12-02)||40.23%|
|1 year (2022-06-02)||133.71%|
|2 years (2021-06-04)||11.13%|
|3 years (2020-06-04)||45.48%|
|5 years (2018-06-04)||7.85%|
Revance The financials
|Revenue TTM||$156.6 million|
|Gross profit TTM||$-20,388,000|
|Return on assets TTM||-28.21%|
|Return on equity TTM||-879.28%|
|Market capitalisation||$2.6 billion|
TTM: trailing 12 months
Revance The share dividends
We're not expecting Revance The to pay a dividend over the next 12 months.
Revance The share price volatility
Over the last 12 months, Revance The's shares have ranged in value from as little as $11.27 up to $37.98. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Revance The's is 0.8392. This would suggest that Revance The's shares are less volatile than average (for this exchange).
Revance The overview
Revance Therapeutics, Inc. , a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials for the treatment of glabellar (frown) lines and cervical dystonia; is in phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe lateral canthal lines; and has completed Phase II clinical trials for the treatment of adult upper limb spasticity and plantar fasciitis. It is also developing OnabotulinumtoxinA, a biosimilar to BOTOX. The company also offers Resilient Hyaluronic Acid (RHA) dermal filler for the correction of moderate to severe dynamic facial wrinkles; RHA Redensity, a dermal filler for the treatment of moderate to severe dynamic perioral rhytids; and OPUL Relational Commerce Platform, a financial technology platform. It has a collaboration and license agreement with Viatris Inc. to develop, manufacture, and commercialize onabotulinumtoxinA.
Stocks similar to Revance The
Revance The in the news
Revance to Participate in Upcoming Investor Conferences
Here’s Why Revance Therapeutics (RVNC) Outperformed in Q1
Revance Therapeutics, Inc. (RVNC) Reports Q1 Loss, Tops Revenue Estimates
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.Read more…
Best stock app for beginners for 2023
The best stock trading app for beginners is easy to use and offers free trades.Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.Read more…
More guides on Finder
Best bad credit loans in Prince Edward Island
Compare some of the best bad credit loans in PEI.
Your guide to the features, interest rates and fees to expect when you apply for a short-term loan with Credito.
5 apps like Bree in Canada
Pay for unexpected bills and avoid overdrafts when you sign up for apps like Bree.
Debt Relief Canada (reliefcanada.ca) review
Take a closer look at the debt relief solutions, features and fees of Debt Relief Canada.
Desjardins Online Brokerage (Disnat) review 2023
Learn more about Desjardins Online Brokerage (Disnat) to see if it’s the right broker for you.
Guide to finding the best prepaid card in Canada in June 2023
We show you the best prepaid credit cards in Canada, whether you’re looking for a prepaid card with no fees, cash back rewards, or travel perks, or more.
How to buy Sui (SUI) in Canada
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
5 apps like Nyble in Canada
Compare apps like Nyble in Canada to access emergency funding.
Your guide to buying and financing a car in Canada with RightRide.
Compare bad credit car loans in BC
Your guide to bad credit car loans in BC and how to find the right financing for your needs.
Ask an Expert
You must be logged in to post a comment.